TD Asset Management Inc Sells 111 Shares of STERIS plc $STE

TD Asset Management Inc reduced its stake in shares of STERIS plc (NYSE:STE) by 0.3% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 37,618 shares of the medical equipment provider’s stock after selling 111 shares during the period. TD Asset Management Inc’s holdings in STERIS were worth $9,037,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. Geneos Wealth Management Inc. lifted its position in shares of STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 104 shares in the last quarter. Zions Bancorporation National Association UT purchased a new position in shares of STERIS in the 1st quarter worth about $37,000. Golden State Wealth Management LLC grew its position in STERIS by 503.0% during the first quarter. Golden State Wealth Management LLC now owns 199 shares of the medical equipment provider’s stock valued at $45,000 after acquiring an additional 166 shares during the last quarter. Costello Asset Management INC purchased a new position in shares of STERIS in the first quarter worth about $45,000. Finally, Wayfinding Financial LLC purchased a new stake in shares of STERIS during the first quarter valued at approximately $46,000. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on STE. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 14th. KeyCorp boosted their price target on STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 22nd. Morgan Stanley increased their price target on STERIS from $276.00 to $295.00 and gave the company an “overweight” rating in a report on Friday, August 8th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a report on Tuesday, October 14th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $273.50.

Insider Buying and Selling at STERIS

In other news, VP Renato Tamaro sold 3,204 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $249.24, for a total value of $798,564.96. Following the completion of the sale, the vice president owned 7,221 shares of the company’s stock, valued at approximately $1,799,762.04. This represents a 30.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Daniel A. Carestio sold 159 shares of the business’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $241.82, for a total value of $38,449.38. Following the completion of the transaction, the chief executive officer directly owned 51,096 shares of the company’s stock, valued at approximately $12,356,034.72. The trade was a 0.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 18,868 shares of company stock valued at $4,585,389. 1.07% of the stock is owned by corporate insiders.

STERIS Stock Performance

Shares of NYSE:STE opened at $240.25 on Monday. The stock has a market capitalization of $23.66 billion, a P/E ratio of 36.79 and a beta of 1.01. STERIS plc has a 52 week low of $200.98 and a 52 week high of $253.00. The firm has a fifty day simple moving average of $245.08 and a two-hundred day simple moving average of $236.43. The company has a quick ratio of 1.53, a current ratio of 2.22 and a debt-to-equity ratio of 0.27.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, August 6th. The medical equipment provider reported $2.34 EPS for the quarter, topping analysts’ consensus estimates of $2.32 by $0.02. The firm had revenue of $1.40 billion during the quarter, compared to analysts’ expectations of $1.36 billion. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The company’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.03 EPS. On average, analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 26th. Stockholders of record on Thursday, September 4th were given a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. This is a positive change from STERIS’s previous quarterly dividend of $0.57. The ex-dividend date was Thursday, September 4th. STERIS’s dividend payout ratio is 38.59%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.